CEBP Meeting Calendar Targets
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 1364, July 1, 2007. Published Online First June 21, 2007;
doi: 10.1158/1055-9965.EPI-06-1033
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1055-9965.EPI-06-1033v1
16/7/1364    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chavarro, J. E.
Right arrow Articles by Ma, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chavarro, J. E.
Right arrow Articles by Ma, J.
Related Collections
Right arrow Risk Assessment
Right arrow Risk Assessment: Biomarkers

A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk

Jorge E. Chavarro1, Meir J. Stampfer1,2,3, Haojie Li3, Hannia Campos1, Tobias Kurth2,4 and Jing Ma3

Departments of 1 Nutrition and 2 Epidemiology, Harvard School of Public Health and 3 The Channing Laboratory and 4 Divisions of Aging and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Jorge E. Chavarro, Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. Phone: 617-432-4584; Fax: 671-432-2435. E-mail: jchavarr{at}hsph.harvard.edu

Background: Animal models suggest that n-3 fatty acids inhibit prostate cancer proliferation, whereas n-6 fatty acids promote it, but epidemiologic studies do not uniformly support these findings.

Methods: A nested case-control study was conducted among 14,916 apparently healthy men who provided blood samples in 1982. Blood fatty acid levels were determined for 476 men diagnosed with prostate cancer during a 13-year follow-up and their matched controls. Conditional logistic regression was used to estimate the relative risks (RR) and 95% confidence intervals (95% CI) of total, non-aggressive (stage A/B and Gleason < 7) and aggressive (stage C/D, Gleason ≥ 7, subsequent distant metastasis or death) prostate cancer associated with blood levels of specific fatty acids expressed as percentages of total fatty acids.

Results: Whole blood levels of all long-chain n-3 fatty acids examined and of linoleic acid were inversely related to overall prostate cancer risk (RRQ5vs.Q1, 0.59; 95% CI, 0.38-0.93; Ptrend = 0.01 for total long-chain n-3 fatty acids and RRQ5vs.Q1, 0.62; 95% CI, 0.41-0.95; Ptrend = 0.03 for linoleic). Blood levels of {gamma}-linolenic and dihomo-{gamma}-linolenic acids, fatty acids resulting from the metabolism of linoleic acid, were directly associated with prostate cancer (RR, 1.41; 95% CI, 0.94-2.12; Ptrend = 0.05 for {gamma}-linolenic and RR, 1.54; 95% CI, 1.03-2.30; Ptrend = 0.02 for dihomo-{gamma}-linolenic acid). Levels of arachidonic and {alpha}-linolenic acids were unrelated to prostate cancer.

Conclusions: Higher blood levels of long-chain n-3 fatty acids, mainly found in marine foods, and of linoleic acid, mainly found in non-hydrogenated vegetable oils, are associated with a reduced risk of prostate cancer. The direct associations of linoleic acid metabolites with prostate cancer risk deserve further investigation. (Cancer Epidemiol Biomarkers Prev 2007;16(7):1364–70)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J. A Simon, Y.-H. Chen, and S. Bent
The relation of {alpha}-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1558S - 1564S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. K Virtanen, D. Mozaffarian, S. E Chiuve, and E. B Rimm
Fish consumption and risk of major chronic disease in men
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1618 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. E Chavarro, M. J Stampfer, M. N Hall, H. D Sesso, and J. Ma
A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1297 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. E. Chavarro, M. J. Stampfer, H. Campos, T. Kurth, W. C. Willett, and J. Ma
A Prospective Study of Trans-Fatty Acid Levels in Blood and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 95 - 101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.